Cargando…
An Integrated In Vivo/In Vitro Protein Production Platform for Site-Specific Antibody Drug Conjugates
The XpressCF+(®) cell-free protein synthesis system is a robust platform for the production of non-natural amino acids containing antibodies, which enable the site-specific conjugation of homogeneous antibody drug conjugates (ADCs) via click chemistry. Here, we present a robust and scalable means of...
Autores principales: | Hanson, Jeffrey, Groff, Dan, Carlos, Abi, Usman, Hans, Fong, Kevin, Yu, Abigail, Armstrong, Stephanie, Dwyer, Allison, Masikat, Mary Rose, Yuan, Dawei, Tran, Cuong, Heibeck, Tyler, Zawada, James, Chen, Rishard, Hallam, Trevor, Yin, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045668/ https://www.ncbi.nlm.nih.gov/pubmed/36978695 http://dx.doi.org/10.3390/bioengineering10030304 |
Ejemplares similares
-
A simplified and robust protocol for immunoglobulin expression in E
scherichia coli cell‐free protein synthesis systems
por: Cai, Qi, et al.
Publicado: (2015) -
RF1 attenuation enables efficient non-natural amino acid incorporation for production of homogeneous antibody drug conjugates
por: Yin, Gang, et al.
Publicado: (2017) -
Development of an E. coli strain for cell‐free ADC manufacturing
por: Groff, Dan, et al.
Publicado: (2021) -
Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system
por: Xu, Yiren, et al.
Publicado: (2014) -
Immunization with cell‐free‐generated vaccine protects from Porphyromonas gingivalis‐induced alveolar bone loss
por: Huang, Nasi, et al.
Publicado: (2019)